NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), Superior Group of Companies, Inc. (NASDAQ: SGC ), ACM Research, Inc. (NASDAQ: ACMR ), Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI ), Customers Bancorp, Inc (NYSE: CUBI ), and GW Pharmaceuticals PLC (NASDAQ: GWPH ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CMTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CMTA SGC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SGC ACMR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACMR ACBI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACBI CUBI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CUBI GWPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=GWPH
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), Superior Group of Companies, Inc. (NASDAQ: SGC ), ACM Research, Inc. (NASDAQ: ACMR ), Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI ), Customers Bancorp, Inc (NYSE: CUBI ), and GW Pharmaceuticals PLC (NASDAQ: GWPH ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 4th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CLEMENTIA PHARMACEUTICALS INC. (CMTA) REPORT OVERVIEW
Clementia Pharmaceuticals' Recent Financial Performance
Clementia Pharmaceuticals is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The estimated EPS forecast for the next fiscal year is -$1.79 and is expected to report on February 27th, 2019.
To read the full Clementia Pharmaceuticals Inc. (CMTA) report, download it here: http://Fundamental-Markets.com/register/?so=CMTA
-----------------------------------------
SUPERIOR GROUP OF COMPANIES, INC. (SGC) REPORT OVERVIEW
Superior Group of Companies' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Superior Group of Companies reported revenue of $73.09MM vs $60.99MM (up 19.84%) and basic earnings per share $0.17 vs $0.27 (down 37.04%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Superior Group of Companies reported revenue of $266.81MM vs $252.60MM (up 5.63%) and basic earnings per share $1.04 vs $1.04 (unchanged). Superior Group of Companies is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $1.52 and is expected to report on February 28th, 2019.
To read the full Superior Group of Companies, Inc. (SGC) report, download it here: http://Fundamental-Markets.com/register/?so=SGC
-----------------------------------------
ACM RESEARCH, INC. (ACMR) REPORT OVERVIEW
ACM Research's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, ACM Research reported revenue of $9.74MM vs $5.66MM (up 72.14%) and basic earnings per share -$0.18 vs -$0.43. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ACM Research reported revenue of $36.51MM vs $27.37MM (up 33.37%) and basic earnings per share -$0.05 vs $0.30. ACM Research is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The estimated EPS forecast for the next fiscal year is $0.70 and is expected to report on March 4th, 2019.
To read the full ACM Research, Inc. (ACMR) report, download it here: http://Fundamental-Markets.com/register/?so=ACMR
-----------------------------------------
ATLANTIC CAPITAL BANCSHARES, INC. (ACBI) REPORT OVERVIEW
Atlantic Capital Bancshares' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Atlantic Capital Bancshares reported interest income of $25.98MM vs $22.46MM (up 15.68%) and basic earnings per share $0.20 vs $0.13 (up 53.85%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Atlantic Capital Bancshares reported interest income of $96.27MM vs $88.22MM (up 9.13%) and basic earnings per share -$0.15 vs $0.54. Atlantic Capital Bancshares is expected to report earnings on July 27th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.17. The estimated EPS forecast for the next fiscal year is $1.14 and is expected to report on February 4th, 2019.
To read the full Atlantic Capital Bancshares, Inc. (ACBI) report, download it here: http://Fundamental-Markets.com/register/?so=ACBI
-----------------------------------------
CUSTOMERS BANCORP, INC (CUBI) REPORT OVERVIEW
Customers' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Customers reported interest income of $96.96MM vs $83.09MM (up 16.69%) and basic earnings per share $0.65 vs $0.73 (down 10.96%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Customers reported interest income of $372.85MM vs $322.54MM (up 15.60%) and basic earnings per share $2.10 vs $2.51 (down 16.33%). Customers is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.78. The estimated EPS forecast for the next fiscal year is $3.27 and is expected to report on January 23rd, 2019.
To read the full Customers Bancorp, Inc (CUBI) report, download it here: http://Fundamental-Markets.com/register/?so=CUBI
-----------------------------------------
GW PHARMACEUTICALS PLC (GWPH) REPORT OVERVIEW
GW Pharmaceuticals' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, GW Pharmaceuticals reported revenue of $3.35MM vs $2.04MM (up 64.35%) and basic earnings per share -$3.12 vs -$1.70. For the twelve months ended September 30th, 2017 vs September 30th, 2016, GW Pharmaceuticals reported revenue of $10.44MM vs $14.69MM (down 28.94%) and basic earnings per share -$6.60 vs -$4.02. GW Pharmaceuticals is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$2.07. The estimated EPS forecast for the next fiscal year is -$6.05 and is expected to report on December 3rd, 2018.
To read the full GW Pharmaceuticals PLC (GWPH) report, download it here: http://Fundamental-Markets.com/register/?so=GWPH
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
